Tuesday 4 September 2018

Construction Chemicals Analysis Market Likely to Reach a Valuation of around USD 67.61 Billion by 2024: Grand view Research, Inc.


The global construction chemicals market size is expected to reach USD 67.61 billion by 2024, according to a new report by Grand View Research, Inc. The global market is estimated to register a CAGR of 6.3% during the forecast period. Rising urbanization, coupled with various infrastructural developments are boosting market growth.
Construction chemicals are the chemical compounds used to modify the properties of the construction materials. These chemicals reduce the amount of water used in a construction. They play a crucial role in improving the overall performance of a building and non-building structures. These chemicals can be categorized into different product segments including concrete admixtures, construction adhesives, construction sealants, protective coatings, and waterproofing chemicals.
The most important group of raw materials found in almost every construction chemical formulation are polymers. In many cases, the chemical producer, construction chemical manufacturer, and end-user work together on the formulation to get the desired product. Most of the key players in this market spend around 3% of their total expenditure on R&D activities every year. BASF SE, The Dow Chemical Company, Bayer Material Science, Wacker Chemie AG, and SABIC are some of the major raw material suppliers for these chemicals.
China is the largest regional market for construction chemicals. The building and construction industry in China has been growing at a rate of around 16.2% annually. Non-residential building is expected to be the largest construction market. Rapid urbanization is one of the major factors for the growth of construction industry in China. In 2014, Chinese government launched “New Style Urbanization Plan (2014-2020)” to build green cities, smart cities, and cultural cities. In addition, EU-China partnership and agreements for urban development have played an important role in the development of construction sector in China.
Non-residential and infrastructure end-use segment is expected to have high penetration due to rapid urbanization in emerging economies. On the other hand, residential segment is expected to witness the fastest growth rate of 6.6% durign the forecast years, in terms of revenue. Construction chemicals are used in new buildings, as well as for repair and rehabilitation of the old buildings. They reduce the water and cement content in the concrete and impart chemical properties such as cross-linking, which result in increased strength of the mortar.
Full Research Report On construction chemicals market Analysis:
https://www.grandviewresearch.com/industry-analysis/construction-chemicals-market

Further key findings from the study suggest:
·         The global market for construction chemicals stood at 33,135 kilo tons in 2015 and is projected to expand at a volume-based CAGR of 5.2% over the forecast period
·         The residential segment accounted for 33.0% of the total market volume in 2015
·         Sluggish growth in the European construction sector due to rising utility expenditure is expected to limit the market development in the region
·         Major companies in the market include BASF SE; Pidilite Industries Ltd.; FOSROC Chemicals India Pvt. Ltd.; Sika AG; W. R. Grace and Co.; Dow Chemical Co.; RPM International, Inc.; Arkema S.A.; and Mapei S.p.A.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/specialty-bio-based-and-water-soluble-polymers
Grand View Research has segmented the global construction chemicals market on the basis of product, end use, and region:
Construction Chemicals Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)
·         Concrete Admixtures
·         Concrete Adhesives
·         Concrete Sealants
·         Protective Coatings
Construction Chemicals End-use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)
·         Residential
·         Non-residential & Infrastructure
Construction Chemicals Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
·         Europe
o    Germany
o    Italy
o    France
o    U.K.
·         Asia Pacific
o    China
o    India
o    Japan
o    South Korea
·         Latin America
o    Brazil
·         Middle East & Africa (MEA)


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/

Friday 31 August 2018

Molecular Weight Marker Market Size To Reach $1.1 Billion By 2025: Grand View Research, Inc.

U.S. molecular weight marker market, by product, 2014 - 2025 (USD Million)

The global molecularweight marker market is expected to reach a value of USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by companies including biotechnology and biologics is the major factor that drives the growth during the forecast period. These markers are used by researchers and companies for various applications such as polymerase chain reaction (PCR), northern blotting, southern blotting, and molecular cloning. Thus, the increasing application of these products in R&D is expected to boost growth.
Increasing focus on molecular biology research is another major factor supporting the growth of the molecular weight marker market. Molecular biology research is important to understand interactions between the different systems of a cell, including DNA, RNA, and protein biosynthesis & regulation. Thus, these research activities are very high in developed countries and are growing at a high pace in developing countries including China and India. Hence, there is a growing demand for molecular weight marker for research activities, which is expected to fuel the growth.
Browse Research Report on Molecular Weight Marker Market:

Further key findings from the study suggest:

·         DNA markers was the largest revenue-generating segment of the molecular weight marker market in 2016 and is also expected to showcase the fastest growth during forecast period
·         In the application segment, nucleic acid accounted for the largest share in 2016, owing to the large application of DNA markers in PCR, sequencing, northern blotting, southern blotting, and molecular cloning
·         The academic and research institutes dominated the molecular weight marker market in terms of revenue in 2016, due to the large focus on molecular biology and other related research activities
·         The North America molecular weight market is the leading regional sector and accounted for the largest revenue share in 2016, mainly due to the existence of large number of research laboratories and biotechnology companies in this region
·         The Asia Pacific market is projected to grow at a highest growth rate during the forecast period. The developing healthcare infrastructure and escalating interest on molecular research in the Asian countries such as India and China is a major factor contributing to the growth in this region
·         Some of the major players include Thermo Fisher Scientific, Inc.; F Hoffmann-La Roche Ltd.; Merck KGaA; Agilent Technologies; QIAGEN; TAKARA BIO, INC.; Bio-Rad Laboratories, Inc.; Promega Corporation; and New England Biolabs

View more reports of this category by Grand View Research at

Grand View Research has segmented the molecular weight marker market on the basis of product, type, application, end-use, and region:
Molecular Weight Marker Product Outlook (Revenue, USD Million; 2014 - 2025)
·         DNA markers
o    Below 50 bp
o    50 bp to 100 bp
o    100 bp to 1 kb
o    1 kb to 5 kb
o    Above 5 kb
·         Protein markers
o    Below 10 kDa
o    10 k Da to 100 kDa
o    100 k Da to 200 kDa
o    Above 200 kDa
·         RNA markers
Molecular Weight Marker Type Outlook (Revenue, USD Million; 2014 - 2025)
·         Prestained markers
·         Unstained markers
·         Specialty markers
Molecular Weight Marker Application Outlook (Revenue, USD Million; 2014 - 2025)
·         Nucleic acid applications
o    PCR
o    Sequencing
o    Northern blotting
o    Southern blotting
o    Molecular cloning
o    Others
·         Proteomics applications   
o    Western blotting
o    Gel extraction
o    Others
Molecular Weight Marker End-Use Outlook (Revenue, USD Million; 2014 - 2025)
·         Academic and research institutes
·         Pharmaceutical and biotechnology companies
·         CROs
·         Others

View press release of this research report by Grand View Research:

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and healthcare.

For more information: www.grandviewresearch.com

Genomics Market Size To Reach $27.6 Billion By 2025: Grand View Research, Inc.


The global Genomics market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.7% during the forecast period. Over the past few years, there have been significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in usage of genomic studies in clinical practices, which is reflected by growing trend of targeted therapies.
Results from genomic studies enable a better understanding of diseases and underlying mechanisms for researchers, physicians, and consumers. This facilitates evidence-based decision-making and thus, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools are motivating healthcare community to create precision-based therapies from surplus, available DNA data.
Advancements in genomics and associated technologies are significantly impacting crop genetics. Technological advancements in sequencing facilitate genomes & transcriptomes sequencing for several crops. Although a reference genome exists for several crops, resequencing and gene expression studies are required for in-depth study of key genes contributing to desired trait. Implementation of this information in crop breeding helps in development of advanced crops.
Companies are involved in strategic alliances with global as well as local entities to boost their revenue generation and enhance their share in the market. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company. Through the collaboration, the latter was able to deploy former’s molecular information solutions and comprehensive genomic profiling for identification of predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials. Such initiatives are aimed at increasing the adoption of genomic information in cancer management.
Browse Research Report on Genomics Market:

Further Key Findings From the Report Suggest:

·         High volume requirement and high cost of specific reagents contribute to substantial revenue growth. Companies are incorporating the trend of offering varied reagents that simplify workflow process
·         NGS-based services hold a major share in the genomics services segment due to their rapid adoption of whole genome sequencing and application of sequence databases for disease screening and prognosis
·         Biomarkers exhibit high clinical potential and efficiency across treatment of wide range of diseases. Use of predictive biomarkers for diagnosis and monitoring take cancer eradication a step further. Moreover, organizations and programs such as National Biomarker Development Alliance (NBDA) are actively participating in development of novel biomarkers for cancer diagnosis
·         Growing interest of pharmaceutical and biotechnology companies in genomics is expected to drive the market in the coming years.
·         As patients are focusing more on their health, direct-to-consumer (DTC) laboratory testing is increasingly gaining popularity. DTC genetic tests enable consumers to access information about their genetics without necessarily including healthcare professionals in the process
·         Asia Pacific is the most promising region, exhibiting a CAGR of 12.7% during the forecast period. The growth of the region can be attributed to improving healthcare infrastructure
·         Some of the key players in the market are BGI; Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Foundation Medicine, Inc., 23andMe, Inc.; Danaher; Illumina, Inc.; Pacific Biosciences; Oxford Nanopore Technologies.; F. Hoffmann-La Roche Ltd.; and Myriad Genetics, Inc.
·         Market participants are engaged in making the technology available to users at a lower price and in a compact form.

View more reports of this category by Grand View Research at

Grand View Research has segmented the global genomics market on the basis of product & service, application & technology, end-use, and region:
Genomics Product and Service Outlook (Revenue, USD Million, 2014 - 2025)
·         Products
o    Instruments/Systems/Software
o    Consumables & Reagents
·         Services
o    Core Genomics Services
o    NGS-based Services
o    Biomarker Translation Services
o    Computational Services
o    Others
Genomics Application & Technology Outlook (Revenue, USD Million, 2014 - 2025)
·         Functional Genomics
o    Transfection
o    Real-time PCR
o    RNA interference
o    Mutational analysis
o    SNP analysis
o    Microarray analysis
·         Epigenetics
o    Bisulfite sequencing
o    Chromatin immunoprecipitation (ChIP & ChIP-Seq)
o    Methylated DNA immunoprecipitation (MeDIP)
o    High resolution melt (HRM)
o    Chromatin accessibility assays
o    Microarray analysis
·         Pathway Analysis
o    Bead-based analysis
o    Microarray analysis
o    Real-time PCR
o    Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
·         Biomarker Discovery
o    Mass spectrometry
o    Real-time PCR
o    Microarray analysis
o    Statistical analysis
o    Bioinformatics
o    DNA sequencing
·         Others
Genomics End-use Outlook (Revenue, USD Million, 2014 - 2025)
·         Clinical Research
·         Academic and Government Institutes
·         Hospitals and Clinics
·         Pharmaceutical and Biotechnology Companies
·         Other End Users
View press release of this research report by Grand View Research:


About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and healthcare.

For more information: www.grandviewresearch.com